Edition:
United States

KindredBio Announces Positive Results From Pivotal Study Of Zimeta Oral


Monday, 4 Dec 2017 08:02am EST 

Dec 4 (Reuters) - Kindred Biosciences Inc ::KINDREDBIO ANNOUNCES POSITIVE RESULTS FROM PIVOTAL STUDY OF ZIMETA ORAL FOR FEVER IN HORSES.KINDRED BIOSCIENCES INC - ‍BASED ON PRELIMINARY REVIEW OF SAFETY DATA, DRUG ZIMETA APPEARS TO BE WELL TOLERATED ​.KINDRED BIOSCIENCES INC - CO ANTICIPATES SUBMITTING EFFECTIVENESS TECHNICAL SECTION OF NEW ANIMAL DRUG APPLICATION IN EARLY 2018​. 

Company Quote

11.98
-0.18 -1.48%
10:46am EST